<DOC>
	<DOCNO>NCT01137110</DOCNO>
	<brief_summary>Our primary objective compare two treatment option prevention seizures follow subarachnoid hemorrhage determine short-course regimen levetiracetam efficacious prevention in-hospital seizure compare extended course .</brief_summary>
	<brief_title>Comparison Short Duration Levetiracetam Extended Course Seizure Prophylaxis After Subarachnoid Hemorrhage ( SAH )</brief_title>
	<detailed_description>This prospective , single-center , randomize , control trial . Patients admit spontaneous SAH ( meet enrollment criterion ) randomize either levetiracetam 1000 mg twice daily 3 day levetiracetam 1000mg twice daily hospital discharge .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>1 . Age &gt; 18 year age 2 . Diagnosis spontaneous SAH 1 . SAH secondary trauma arteriovenous malformation 2 . Early death ( define death within 3 day presentation ) 3 . Known allergy levetiracetam 4 . Know seizure history chronic AEDs 5 . Pregnancy 6 . Current incarceration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Subarachnoid Hemorrhage</keyword>
	<keyword>Seizure Prophylaxis</keyword>
	<keyword>Levetiracetam</keyword>
</DOC>